Danske Invest China vs UBS Lux Equity Fund Biotech USD

Danske Invest China vs UBS Lux Equity Fund Biotech USD

1. Danske Invest China

  • Security

    Danske Invest China A

  • Fee

    2.15%

  • ISIN

    LU0178668348

  • Holdings

    14

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 20 holdings in Danske Invest China, where the largest holding is Tencent (8.8), followed by Alibaba Group Holding Ltd (8.75) and Meituan Class B (6.3). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.35) and Moderna (9.21).

All Holdings

Here we compare the holdings in Danske Invest China and UBS Lux Equity Fund Biotech USD.

Danske Invest China UBS Lux Equity Fund Biotech USD
1. Tencent Holdings Ltd
China
8.8 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Alibaba Group Holding Ltd
China
8.75 %
2. Vertex Pharmaceuticals Inc
9.35 %
3. Meituan Class B
China
6.3 %
3. Moderna Inc
9.21 %
4. China Construction Bank Corp Class H
China
6.12 %
4. Alnylam Pharmaceuticals Inc
6.96 %
5. Xiaomi
China
5.07 %
5. AbbVie Inc
USA
5.53 %
6. Pinduoduo Inc
China
3.76 %
6. Gilead Sciences Inc
USA
4.66 %
7. Ping An Insurance Co
China
3.67 %
7. Amgen Inc
4.3 %
8. Trip.com Group Ltd
Singapore
3.62 %
8. BioNTech SE
4.13 %
9. BYD Co Ltd Class H
China
2.56 %
9. Karuna Therapeutics Inc
3.75 %
10. NetEase ADR
China
2.36 %
10. Royalty Pharma Plc
3.37 %
11. JD.com Inc
China
1.47 %
-
12. Xpeng Inc
1.27 %
-
13. Industrial and Commercial Bank of China Ltd Class H
China
1.25 %
-
14. Wuxi AppTec Co Ltd
China
1.01 %
-

The list of fund holdings was last updated on June 5, 2025.